A randomized clinical trial of Premaquick biomarkers versus transvaginal cervical length for pre-induction cervical assessment at term among pregnant women.
Chigozie Geoffrey OkaforGeorge Uchenna ElejeJoseph I AdinmaJoseph Ifeanyichukwu IkechebeluEric O UmehChisolum O OkaforEmmanuel O UgwuJoseph O UgboajaBetrand O NwosuChukwuemeka O EzeamaGerald O UdigweChukwuemeka Chukwubuikem OkoroRichard O EgeonuEvaristus C EzemaOsita S UmeononihuBoniface Chukwuneme OkpalaChidinma C OkaforChukwuemeka J OfojebeChito P IlikaCharlotte B OguejioforChukwudi A OgabidoChijioke C UmeokaforJohn E JamesHillary I ObiagwuLazarus U OkaforAfam B ObidikePrinceston C OkamKenneth N OkekeAnselem O InyaTobechi K NjokuLydia Ijeoma ElejePublished in: SAGE open medicine (2023)
Pre-induction cervical assessment at term with either Premaquick biomarkers or transvaginal ultrasound for cervical length is effective, objective and safe with similar and comparable outcome. However, when compared with women with positive transvaginal ultrasound at initial assessment, women with positive Premaquick test at initial assessment showed a significantly shorter duration of onset of active phase of labour and delivery of baby following induction of labour.